Welcome to our dedicated page for HEALTHEQUITY SEC filings (Ticker: HQY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HealthEquity, Inc. filings document regulatory disclosures for an HSA custodian and consumer-directed benefits administrator. Recent 8-K reports cover operating results and financial condition, guidance furnished under Regulation FD, HSA account and asset metrics, revenue categories, stock repurchase activity, and hedging used to reduce HSA cash repricing risk.
Governance filings record board appointments and committee assignments, annual meeting vote results, auditor ratification, advisory executive compensation votes, executive employment agreement amendments, severance arrangements, equity award terms, and technology-organization leadership responsibility. These disclosures frame the company's capital allocation, compensation governance, risk oversight and public-company reporting obligations.
HEALTHEQUITY, INC. (HQY) director Adrian T. Dillon reported an option exercise and related stock sales. On August 25, 2026, he exercised a stock option for 7,632 shares of common stock at an exercise price of $32.50 per share, acquiring 7,632 shares of common stock.
On the same date, he sold 6,300 shares of common stock at a weighted average price of $104.4718 per share and 1,332 shares at a weighted average price of $105.2557 per share. The filing states these transactions were effected under a Rule 10b5-1 trading plan adopted on December 20, 2025. Dillon continues to hold several stock options with exercise prices between $46.40 and $66.06 expiring from 2027 to 2030.
HealthEquity, Inc. (HQY) reported solid growth for the quarter ended July 31, 2026. Total revenue was $350.7 million, up 8% from a year earlier, driven by higher custodial, service, and interchange revenue. Net income rose to $65.6 million from $59.9 million, and diluted EPS increased to $0.78 from $0.68.
Custodial revenue grew 10% on a higher average yield on HSA cash (3.83% vs. 3.51%) and modest balance growth. Total HSA Assets reached $37.9 billion, up 14% year over year, with $17.4 billion in HSA cash and $20.6 billion in HSA investments. Total Accounts were 17.8 million, including 10.7 million HSAs.
Operating cash flow for the six months was strong at $233.7 million, up from $200.6 million, supporting significant capital returns: HQY repurchased 2.7 million shares for $231.1 million, with $948.4 million remaining under authorization. Long‑term debt stood at $931.1 million, primarily 4.50% Senior Notes due 2029 and Revolving Credit Facility borrowings. Treasury bond forwards used as cash flow hedges generated large unrealized losses recorded in other comprehensive income, reducing accumulated other comprehensive loss to $(69.1 million).
HEALTHEQUITY, INC. (HQY) reported strong results for the second quarter ended July 31, 2026. Revenue was $350.7 million, up 8% year over year, driven by service revenue of $124.4 million, custodial revenue of $175.9 million, and interchange revenue of $50.4 million. Net income rose 10% to $65.6 million, with diluted EPS of $0.78 and a net margin of 19%. Adjusted EBITDA increased 11% to $167.0 million, reaching a record margin of 48%.
HealthEquity ended the quarter with 10.7 million HSAs and Total HSA Assets of $37.9 billion, up 14% year over year, including $17.4 billion in HSA cash and $20.6 billion in HSA investments. The company repurchased 1.2 million shares for $108.1 million, with $948.4 million remaining under its authorization.
For the fiscal year ending January 31, 2027, management raised guidance, targeting revenue of $1.411–$1.421 billion, net income of $242–$248 million (diluted EPS of $2.88–$2.96), non-GAAP net income of $392–$398 million (non-GAAP EPS of $4.66–$4.73), and Adjusted EBITDA of $628–$636 million.
A Rule 144 notice for HEALTHEQUITY, INC. (HQY) states that director Adrian Dillon plans to sell 7,632 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 08/25/2026, with an indicated aggregate market value of $804,412.80. The shares are to be acquired by exercise of stock options for cash and sold on NASDAQ.
Vanguard Portfolio Management LLC filed an amended ownership report stating beneficial ownership of 4,137,941 shares of HealthEquity Inc common stock as of June 30, 2026, representing 4.94% of the class.
Vanguard reports sole power to vote 80,298 shares and sole dispositive power over all 4,137,941 shares, with no shared voting or dispositive power. The position reflects securities held by various Vanguard-managed funds and client accounts; no single other person has an interest in more than 5% of the securities attributed to this holding. The filing is signed by My Trieu-Gatt as Authorized Signatory and Head of Global Fund Administration.
Wasatch Advisors reports beneficial ownership of 7,960,735 shares of HealthEquity Inc common stock, representing 9.5% of the class as of 06/30/2026. The firm is organized in Delaware and filed this as Amendment No. 4 to its ownership report.
Wasatch Advisors holds sole voting power over 5,564,289 shares and sole dispositive power over all 7,960,735 shares, with no shared voting or dispositive authority. The report is signed by CEO Mike Yeates on 07/15/2026.
HealthEquity, Inc. executive Michael Henry Fiore, EVP and Chief Commercial Officer, reported an open-market sale of 2,354 shares of Common Stock at $95.00 per share on July 10, 2026. The transaction was executed under a Rule 10b5-1 trading plan. Following the sale, Fiore directly holds 52,244 shares.
HealthEquity, Inc. Chief Customer Officer Michael Gathright reported a tax-withholding disposition of 2,270 shares of Common Stock on July 9, 2026, at $93.0661 per share to satisfy tax obligations. After this compensation-related transaction, he directly holds 39,893 shares of Common Stock.
HealthEquity, Inc. (HQY) filed a notice covering potential sales of its common stock by an affiliated holder through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists 2,354 shares of common stock, linked to Restricted Stock Units acquired from the issuer on 07/01/2026, with an indicated value of $223,182.74 and NASDAQ trading. It also notes prior Rule 10b5-1 sales for Michael Fiore of 2,470 shares for $234,650.00 on 07/02/2026 and 3,142 shares for $298,490.00 on 05/29/2026 during the past three months.